About
GENETON Ltd. is a biotechnology company focused on liquid biopsy and cell-free DNA (cfDNA) solutions for cancer genomics and precision medicine. We work at the intersection of molecular biology, genomics, and clinical innovation to develop advanced approaches for minimally invasive cancer detection and monitoring. Through collaboration with researchers, clinicians, and industry partners, we aim to translate cutting-edge genomic technologies into real-world healthcare impact.
Areas of Activity
HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research (RIA)HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease (RIA)HORIZON_MISS-2027-02-CANCER-01 Leveraging functional genomics to reveal novel targets for cancer treatmentHORIZON_MISS-2027-02-CANCER-05 Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines